News

Celebrate Independence: Wilma™ Sets ABA Practices Free from Manual Workflows with Powerful Patient Relationship Management

AI-Powered Software Empowers ABA Practices to Strengthen Patient Relationships and Streamline Workflows with Next-Generation Tools DIABLO, Calif., July 3, 2025…

6 months ago

IceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025

CAESAREA, Israel, July 3, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive…

6 months ago

NUS researchers develop novel material for water quality monitoring device

Introducing ReSURF sensor – an ultrafast, stretchable, self-healing and recyclable sensing device that enables on-site, real-time surveillance of water quality…

6 months ago

Esaote presents at ECVS 2025 the new generation of veterinary MRI, Vet -MR Grande ELITE

GENOA, Italy and ANTWERP, Belgium, July 3, 2025 /PRNewswire/ -- Esaote, a leading company in the field of medical diagnostic imaging,…

6 months ago

Morgan AH Medical Unveils Patented Rolling Expandable Bathtub at Abilities Expo Chicago – Hailed as a “Game Changer” for Accessible Bathing

Chicago, Illinois--(Newsfile Corp. - July 3, 2025) - Morgan AH Medical made headlines at this year's Abilities Expo Chicago (June…

6 months ago

Hemostemix Announces its 10th Publication: A Molecular Strategy for the Treatment of Heart Failure: Response to BioCardia’s Cardiamp Heart Failure Trial

Calgary, Alberta--(Newsfile Corp. - July 3, 2025) -  Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is proud to share the…

6 months ago

Apollo Biowellness, Inc. Re-Files Application with OTCMarkets.com

North Bergen, New Jersey--(Newsfile Corp. - July 3, 2025) - Apollo Biowellness, Inc. (OTC Pink: KOAN) (the "Company") announces that…

6 months ago

AAMI Aligns With National Academy of Medicine AI Code of Conduct

AI Code of Conduct’s six core principles key to ensuring the safe and effective use of AI technologiesArlington, VA, July…

6 months ago

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

Vancouver, Canada, July 03, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

6 months ago